{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T19:39:13Z","timestamp":1769110753041,"version":"3.49.0"},"reference-count":46,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2006,4,1]],"date-time":"2006-04-01T00:00:00Z","timestamp":1143849600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Cardiac Failure"],"published-print":{"date-parts":[[2006,4]]},"DOI":"10.1016\/j.cardfail.2006.01.002","type":"journal-article","created":{"date-parts":[[2006,4,19]],"date-time":"2006-04-19T17:42:54Z","timestamp":1145468574000},"page":"240-245","source":"Crossref","is-referenced-by-count":33,"title":["Aldosterone Antagonism Improves Endothelial-Dependent Vasorelaxation in Heart Failure via Upregulation of Endothelial Nitric Oxide Synthase Production"],"prefix":"10.1016","volume":"12","author":[{"given":"Hoang M.","family":"Thai","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bao Q.","family":"Do","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Trung D.","family":"Tran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohamed A.","family":"Gaballa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steven","family":"Goldman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cardfail.2006.01.002_bib1","doi-asserted-by":"crossref","first-page":"40D","DOI":"10.1016\/0002-9149(90)90475-G","article-title":"Effects of enalapril and neuroendocrine activation on prognosis in severe congestive heart failure","volume":"66","author":"Swedberg","year":"1990","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.cardfail.2006.01.002_bib2","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1161\/01.CIR.82.5.1730","article-title":"Hormones regulating cardiovascular function in patients with severe congestive heart failure and their relation to mortality","volume":"82","author":"Swedberg","year":"1990","journal-title":"Circulation"},{"key":"10.1016\/j.cardfail.2006.01.002_bib3","first-page":"293","article-title":"Effect of enalapril on survival in patients with reduced left ventricular ejection fraction and congestive heart failure","volume":"319","author":"The SOLVD Investigators","year":"1988","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cardfail.2006.01.002_bib4","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1056\/NEJMoa010713","article-title":"the Valsartan Heart Failure Trial Investigators. A randomized trial of the angiotensin receptor valsartan in chronic heart failure","volume":"345","author":"Cohn","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cardfail.2006.01.002_bib5","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1056\/NEJM199909023411001","article-title":"The effect of spironolactone on morbidity and mortality in patients with severe heart failure","volume":"341","author":"Pitt","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cardfail.2006.01.002_bib6","doi-asserted-by":"crossref","first-page":"N103","DOI":"10.1093\/eurheartj\/16.suppl_N.103","article-title":"Aldosterone escape during ACE inhibitor therapy in chronic heart failure","volume":"16","author":"Struthers","year":"1995","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cardfail.2006.01.002_bib7","doi-asserted-by":"crossref","first-page":"2647","DOI":"10.1016\/S0149-2918(03)80326-0","article-title":"The cardiovascular effects of eplerenone, a selective aldosterone receptor antagonist","volume":"25","author":"Davis","year":"2003","journal-title":"Clin Ther"},{"key":"10.1016\/j.cardfail.2006.01.002_bib8","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/0922-4106(95)90018-7","article-title":"Aldosterone inhibits nitric oxide synthesis in rat vascular smooth muscle cells induced by interleukin-1B","volume":"290","author":"Ikeda","year":"1995","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.cardfail.2006.01.002_bib9","doi-asserted-by":"crossref","first-page":"51K","DOI":"10.1016\/0002-9149(90)91281-A","article-title":"Spironolactone in the management of congestive heart failure","volume":"65","author":"Muller","year":"1990","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.cardfail.2006.01.002_bib10","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/S0008-6363(97)00091-6","article-title":"Aldosterone blockade reduces vascular collagen turnover, improves heart rate variability and reduces early morning rise in heart rate in heart failure patients","volume":"35","author":"MacFadyen","year":"1996","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.cardfail.2006.01.002_bib11","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1016\/S0002-9149(00)00729-3","article-title":"Effect of spironolactone on ventricular arrhythmias in congestive heart failure secondary to idiopathic dilated or ischemic cardiomyopathy","volume":"85","author":"Ramires","year":"2000","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.cardfail.2006.01.002_bib12","doi-asserted-by":"crossref","first-page":"2700","DOI":"10.1161\/01.CIR.102.22.2700","article-title":"Limitation of excessive extracellular matrix turnover may contribute to survival benefit of spironolactone therapy in patients with congestive heart failure","volume":"102","author":"Zannad","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.cardfail.2006.01.002_bib13","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1016\/S0735-1097(00)01129-3","article-title":"Prevention of aortic and cardiac fibrosis by spironolactone in old normotensive rats","volume":"37","author":"Lacolley","year":"2001","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cardfail.2006.01.002_bib14","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1016\/0735-1097(92)90271-N","article-title":"Impaired endothelium mediated vasodilation in the peripheral vasculature of patients with congestive heart failure","volume":"19","author":"Katz","year":"1992","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cardfail.2006.01.002_bib15","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1161\/01.CIR.84.4.1589","article-title":"Endothelium dependent vasorelaxation is attenuated in patients with heart failure","volume":"84","author":"Kubo","year":"1991","journal-title":"Circulation"},{"key":"10.1016\/j.cardfail.2006.01.002_bib16","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1161\/01.RES.69.4.1088","article-title":"Diminished endothelium-derived relaxing factor activity in an experimental model of chronic heart failure","volume":"69","author":"Ontkean","year":"1991","journal-title":"Circ Res"},{"key":"10.1016\/j.cardfail.2006.01.002_bib17","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/0002-8703(93)90926-Z","article-title":"Endothelial function in congestive heart failure","volume":"126","author":"Drexler","year":"1993","journal-title":"Am Heart J"},{"key":"10.1016\/j.cardfail.2006.01.002_bib18","first-page":"H873","article-title":"Effects of AT1 receptor blockade after myocardial infarct on myocardial fibrosis, stiffness, and contractility","volume":"276","author":"Thai","year":"1999","journal-title":"Am J Physiol"},{"key":"10.1016\/j.cardfail.2006.01.002_bib19","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1124\/jpet.103.054916","article-title":"AT1 receptor blockade improves vasorelaxation in heart failure by up-regulation of endothelial nitric oxide synthase via activation of the AT2 receptor","volume":"307","author":"Thai","year":"2003","journal-title":"J Pharmacol Exp Therapeutics"},{"key":"10.1016\/j.cardfail.2006.01.002_bib20","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1016\/S0002-9149(99)80353-1","article-title":"Effects of adding spironolactone to an angiotensin-converting enzyme inhibitor in chronic congestive heart failure secondary to coronary artery disease","volume":"76","author":"Barr","year":"1995","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.cardfail.2006.01.002_bib21","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1056\/NEJMoa030207","article-title":"Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction","volume":"348","author":"Pitt","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cardfail.2006.01.002_bib22","doi-asserted-by":"crossref","first-page":"2325","DOI":"10.1161\/01.CIR.102.19.2325","article-title":"Striking increase of natriuresis by low-dose spironolactone in congestive heart failure only in combination with ACE inhibition","volume":"102","author":"Bauersachs","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.cardfail.2006.01.002_bib23","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1016\/S0735-1097(01)01116-0","article-title":"Effects of spironolactone on plasma brain natriuretic peptide and left ventricular remodeling in patients with congestive heart failure","volume":"37","author":"Tsutamoto","year":"2001","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cardfail.2006.01.002_bib24","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S0306-3623(97)00396-0","article-title":"Effects of spironolactone on exercise capacity and neurohormonal factors in patients with heart failure treated with loop diuretics and ACEI","volume":"31","author":"Kinugawa","year":"1998","journal-title":"Gen Pharmacol"},{"key":"10.1016\/j.cardfail.2006.01.002_bib25","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/S0002-9149(00)01046-8","article-title":"Effects of spironolactone on heart rate variability and left ventricular systolic function in severe ischemic heart failure","volume":"86","author":"Korkmaz","year":"2000","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.cardfail.2006.01.002_bib26","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1038\/288373a0","article-title":"The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine","volume":"288","author":"Furchgott","year":"1980","journal-title":"Nature"},{"key":"10.1016\/j.cardfail.2006.01.002_bib27","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1161\/01.CIR.83.3.1028","article-title":"Contractility and stiffness of noninfarcted myocardium following coronary ligation in rats: Effects of chronic angiotensin converting enzyme inhibition","volume":"83","author":"Litwin","year":"1991","journal-title":"Circulation"},{"key":"10.1016\/j.cardfail.2006.01.002_bib28","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1006\/jmcc.1999.0956","article-title":"Overexpression of endothelium nitric oxide synthase reverses the diminished vasorelaxation in the rat hindlimb in heart failure","volume":"31","author":"Gaballa","year":"1999","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/j.cardfail.2006.01.002_bib29","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.1161\/01.CIR.99.16.2113","article-title":"Decreased activity of the L-arginine-nitric oxide metabolic pathway in patients with congestive heart failure","volume":"99","author":"Katz","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.cardfail.2006.01.002_bib30","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.1161\/01.CIR.100.19.1983","article-title":"Serum from patients with severe heart failure downregulates eNOS and its proapoptotic: Role of tumor necrosis factor-alpha","volume":"100","author":"Agnoletti","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.cardfail.2006.01.002_bib31","doi-asserted-by":"crossref","first-page":"12K","DOI":"10.1016\/0002-9149(90)91269-C","article-title":"Peripheral action of spironolactone: plethysmographic studies","volume":"65","author":"Clement","year":"1990","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.cardfail.2006.01.002_bib32","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1161\/01.HYP.37.2.801","article-title":"Aldosterone receptor antagonism normalizes vascular function in liquorice-induced hypertension","volume":"37","author":"Quashning","year":"2001","journal-title":"Hypertension"},{"key":"10.1016\/j.cardfail.2006.01.002_bib33","doi-asserted-by":"crossref","first-page":"9K","DOI":"10.1016\/0002-9149(90)91268-B","article-title":"Peripheral action of spironolactone: improvement in arterial elasticity","volume":"65","author":"Lagrue","year":"1990","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.cardfail.2006.01.002_bib34","doi-asserted-by":"crossref","first-page":"40A","DOI":"10.1016\/0002-9149(93)90244-7","article-title":"Dose related cardiovascular effects of spironolactone","volume":"71","author":"Schohn","year":"1993","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.cardfail.2006.01.002_bib35","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1053\/euhj.1998.1099","article-title":"Increase relationship between aldosterone and large artery compliance in chronically treated heart failure patients","volume":"19","author":"Duprez","year":"1998","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cardfail.2006.01.002_bib36","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1161\/01.CIR.101.6.594","article-title":"Spironolactone increases nitric oxide bioactivity, improves endothelial vasodilator dysfunction, and suppresses vascular AT1\/AT2 conversion in patients with chronic heart failure","volume":"101","author":"Farquharson","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.cardfail.2006.01.002_bib37","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1161\/01.ATV.0000166516.52477.81","article-title":"Systemic endothelial dysfunction as an early predictor of adverse outcomes in heart failure","volume":"25","author":"Heitzer","year":"2005","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.cardfail.2006.01.002_bib38","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1161\/01.CIR.0000153349.77489.CF","article-title":"Vascular endothelial dysfunction and mortality risk in patients with chronic heart failure","volume":"111","author":"Katz","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.cardfail.2006.01.002_bib39","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1161\/01.CIR.0000030935.89559.04","article-title":"Elevated plasma aldosterone levels despite complete inhibition of the vascular angiotensin-converting enzyme in chronic heart failure","volume":"106","author":"Jorde","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.cardfail.2006.01.002_bib40","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1161\/01.RES.69.2.475","article-title":"Tissue-specific acativation of cardiac angiotensin converting enzyme in experimental heart failure","volume":"69","author":"Hirsch","year":"1991","journal-title":"Circ Res"},{"key":"10.1016\/j.cardfail.2006.01.002_bib41","first-page":"H1818","article-title":"Active renin and angiotensinogen in cardiac interstitial fluid after myocardial infarction","volume":"276","author":"Hirsch","year":"2005","journal-title":"Am J Physiol"},{"key":"10.1016\/j.cardfail.2006.01.002_bib42","doi-asserted-by":"crossref","first-page":"2694","DOI":"10.1161\/01.CIR.99.20.2694","article-title":"Activation of cardiac aldosterone production in rat myocardial infarction","volume":"99","author":"Silvestre","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.cardfail.2006.01.002_bib43","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1007\/BF00877333","article-title":"Neurohumoral and hemodynamic effects of ibopamine in a rat model of chronic myocardial infarction and heart failure","volume":"8","author":"Veldhuisen","year":"1994","journal-title":"Cardiovasc Drugs Therapy"},{"key":"10.1016\/j.cardfail.2006.01.002_bib44","first-page":"H1351","article-title":"Effects of spironolactone and eprosartan on cardiac remodeling and angiotensin-converting enzyme isoform in rats with experimental heart failure","volume":"289","author":"Karram","year":"2005","journal-title":"Am J Physiol"},{"key":"10.1016\/j.cardfail.2006.01.002_bib45","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1161\/01.HYP.0000124251.06056.8e","article-title":"Relations of serum aldosterone to cardiac structure: gender-related differences in the Framingham Heart Study","volume":"43","author":"Vasan","year":"2004","journal-title":"Hypertension"},{"key":"10.1016\/j.cardfail.2006.01.002_bib46","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1161\/01.CIR.82.5.1730","article-title":"Hormones regulating cardiovascular function in patients with severe congestive heart failure and their relation to mortality","volume":"82","author":"Swedberg","year":"1990","journal-title":"Circulation"}],"container-title":["Journal of Cardiac Failure"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1071916406000042?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1071916406000042?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,4,18]],"date-time":"2019-04-18T04:01:05Z","timestamp":1555560065000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1071916406000042"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,4]]},"references-count":46,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2006,4]]}},"alternative-id":["S1071916406000042"],"URL":"https:\/\/doi.org\/10.1016\/j.cardfail.2006.01.002","relation":{},"ISSN":["1071-9164"],"issn-type":[{"value":"1071-9164","type":"print"}],"subject":[],"published":{"date-parts":[[2006,4]]}}}